Aclaris Therapeutics (ACRS) EBT Margin Growth (3y) (2020 - 2026)
Aclaris Therapeutics (ACRS) EBT Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,237.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Aclaris Therapeutics | 705.88 Mn | 705.88 Mn | 1.60 Mn | -52,720.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52,720.00 |
| Dec 31, 2025 | 33,151.00 |
| Sep 30, 2025 | -39,038.00 |
| Jun 30, 2025 | 104,336.00 |
| Mar 31, 2025 | 134,525.00 |
| Dec 31, 2024 | 1.11 Mn |
| Sep 30, 2024 | 209,474.00 |
| Jun 30, 2024 | 153,298.00 |
| Mar 31, 2024 | 266,636.00 |
| Dec 31, 2023 | 936,403.00 |
| Sep 30, 2023 | 44,787.00 |
| Jun 30, 2023 | -151,306.00 |
| Mar 31, 2023 | -24,648.00 |
| Dec 31, 2022 | -112,514.00 |
| Sep 30, 2022 | 223,196.00 |
| Jun 30, 2022 | 652,837.00 |
| Mar 31, 2022 | 212,980.00 |
| Dec 31, 2021 | -1.17 Mn |
| Sep 30, 2021 | 26,890.00 |
| Jun 30, 2021 | -70,926.00 |